The study by Chava et al. indicated that DOT1L inhibition could regulate apoptotic and metabolic pathways as well as upregulate the expression of ULBP1 that increased in NK cell-mediated ovarian cancer eradication (Chava et al., 2021). Here, DOT1L is linked to ovarian cancer.